ロード中...
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer
Immune checkpoint inhibitors have demonstrated effective anti-tumour response in cancer types with high mutation burden (e.g. melanoma) and in subset of cancers with features of genomic instability (e.g. mismatch-repair deficiency). One possible explanation for this effect is the increased expressio...
保存先:
出版年: | PLoS One |
---|---|
主要な著者: | , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Public Library of Science
2019
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483182/ https://ncbi.nlm.nih.gov/pubmed/31022191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215381 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|